
Li N. Komatsu
Examiner (ID: 2294, Phone: (571)270-3534 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658, 1654 |
| Total Applications | 899 |
| Issued Applications | 480 |
| Pending Applications | 135 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19555049
[patent_doc_number] => 20240366841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => CROSSLINKED HYALURONIC ACID-COLLAGEN GELS FOR IMPROVING TISSUE GRAFT VIABILITY AND SOFT TISSUE AUGMENTATION
[patent_app_type] => utility
[patent_app_number] => 18/543288
[patent_app_country] => US
[patent_app_date] => 2023-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18543288
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/543288 | CROSSLINKED HYALURONIC ACID-COLLAGEN GELS FOR IMPROVING TISSUE GRAFT VIABILITY AND SOFT TISSUE AUGMENTATION | Dec 17, 2023 | Abandoned |
Array
(
[id] => 19526804
[patent_doc_number] => 20240350706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => HYALURONIC ACID-COLLAGEN MATRICES FOR DERMAL FILLING AND VOLUMIZING APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/527616
[patent_app_country] => US
[patent_app_date] => 2023-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18527616
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/527616 | HYALURONIC ACID-COLLAGEN MATRICES FOR DERMAL FILLING AND VOLUMIZING APPLICATIONS | Dec 3, 2023 | Abandoned |
Array
(
[id] => 19156111
[patent_doc_number] => 20240148818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => OPHTHALMIC PHARMACEUTICAL COMPOSITION AND ITS PREPARATION METHODS AND APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/518134
[patent_app_country] => US
[patent_app_date] => 2023-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18518134
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/518134 | OPHTHALMIC PHARMACEUTICAL COMPOSITION AND ITS PREPARATION METHODS AND APPLICATIONS | Nov 21, 2023 | Pending |
Array
(
[id] => 19216386
[patent_doc_number] => 20240181090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => CELL PENETRATING PEPTIDE, CONJUGATE COMPRISING SAME, AND COMPOSITION COMPRISING CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 18/502720
[patent_app_country] => US
[patent_app_date] => 2023-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18502720
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/502720 | CELL PENETRATING PEPTIDE, CONJUGATE COMPRISING SAME, AND COMPOSITION COMPRISING CONJUGATE | Nov 5, 2023 | Pending |
Array
(
[id] => 19411755
[patent_doc_number] => 12077561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => CNP compounds
[patent_app_type] => utility
[patent_app_number] => 18/385946
[patent_app_country] => US
[patent_app_date] => 2023-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 30793
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18385946
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/385946 | CNP compounds | Oct 31, 2023 | Issued |
Array
(
[id] => 19990909
[patent_doc_number] => 20250129131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => INSECT NEUROPEPTIDES 1
[patent_app_type] => utility
[patent_app_number] => 18/491957
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491957
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491957 | Insect neuropeptides 1 | Oct 22, 2023 | Issued |
Array
(
[id] => 19995889
[patent_doc_number] => 20250134111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => INSECT NEUROPEPTIDES 9
[patent_app_type] => utility
[patent_app_number] => 18/492076
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18492076
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/492076 | Insect neuropeptides 9 | Oct 22, 2023 | Issued |
Array
(
[id] => 19995889
[patent_doc_number] => 20250134111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => INSECT NEUROPEPTIDES 9
[patent_app_type] => utility
[patent_app_number] => 18/492076
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18492076
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/492076 | Insect neuropeptides 9 | Oct 22, 2023 | Issued |
Array
(
[id] => 20129160
[patent_doc_number] => 12371462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Brown fat-selective adipokines
[patent_app_type] => utility
[patent_app_number] => 18/473627
[patent_app_country] => US
[patent_app_date] => 2023-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 31
[patent_no_of_words] => 7203
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18473627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/473627 | Brown fat-selective adipokines | Sep 24, 2023 | Issued |
Array
(
[id] => 18902701
[patent_doc_number] => 20240018186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 18/460215
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18460215
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/460215 | MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS | Aug 31, 2023 | Pending |
Array
(
[id] => 18921424
[patent_doc_number] => 20240024428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/457482
[patent_app_country] => US
[patent_app_date] => 2023-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18457482
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/457482 | Glucagon-like peptide 1 receptor agonists and uses thereof | Aug 28, 2023 | Issued |
Array
(
[id] => 19316644
[patent_doc_number] => 20240238184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => ANTI-INFLAMMATORY PEPTIDES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/451560
[patent_app_country] => US
[patent_app_date] => 2023-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18451560
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/451560 | ANTI-INFLAMMATORY PEPTIDES, AND USES THEREOF | Aug 16, 2023 | Pending |
Array
(
[id] => 18922956
[patent_doc_number] => 20240025960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => RAGE PROTEINS FOR THE TREATMENT OF FIBROSIS AND DNA DAMAGE MEDIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/450524
[patent_app_country] => US
[patent_app_date] => 2023-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18450524
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/450524 | RAGE PROTEINS FOR THE TREATMENT OF FIBROSIS AND DNA DAMAGE MEDIATED DISEASES | Aug 15, 2023 | Abandoned |
Array
(
[id] => 19536732
[patent_doc_number] => 12129273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Compound with analgesic effect for use in prevention and treatment of pain
[patent_app_type] => utility
[patent_app_number] => 18/227782
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 17199
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18227782
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/227782 | Compound with analgesic effect for use in prevention and treatment of pain | Jul 27, 2023 | Issued |
Array
(
[id] => 18769418
[patent_doc_number] => 20230364180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => COMPOSITION FOR IMPROVING MILD COGNITIVE IMPAIRMENT AND METHOD FOR IMPROVING MILD COGNITIVE IMPAIRMENT
[patent_app_type] => utility
[patent_app_number] => 18/360773
[patent_app_country] => US
[patent_app_date] => 2023-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18360773
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/360773 | COMPOSITION FOR IMPROVING MILD COGNITIVE IMPAIRMENT AND METHOD FOR IMPROVING MILD COGNITIVE IMPAIRMENT | Jul 26, 2023 | Abandoned |
Array
(
[id] => 18955144
[patent_doc_number] => 20240043471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => PREPARING METHOD OF HIGHLY FUNCTIONAL PEPTIDE DERIVED FROM KERATINOCYTE PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/348878
[patent_app_country] => US
[patent_app_date] => 2023-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18348878
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/348878 | PREPARING METHOD OF HIGHLY FUNCTIONAL PEPTIDE DERIVED FROM KERATINOCYTE PROTEIN | Jul 6, 2023 | Abandoned |
Array
(
[id] => 18752455
[patent_doc_number] => 20230355704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => GROWTH PROMOTING PEPTIDES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/330109
[patent_app_country] => US
[patent_app_date] => 2023-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18330109
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/330109 | GROWTH PROMOTING PEPTIDES, AND USES THEREOF | Jun 5, 2023 | Abandoned |
Array
(
[id] => 18861888
[patent_doc_number] => 20230416323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => ERYTHROPOIETIN AND ANALOGS FOR VETERINARY USE
[patent_app_type] => utility
[patent_app_number] => 18/203184
[patent_app_country] => US
[patent_app_date] => 2023-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18203184
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/203184 | ERYTHROPOIETIN AND ANALOGS FOR VETERINARY USE | May 29, 2023 | Abandoned |
Array
(
[id] => 20213594
[patent_doc_number] => 12410236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Compositions comprising PCSK9-binding molecules and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/318343
[patent_app_country] => US
[patent_app_date] => 2023-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6027
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18318343
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/318343 | Compositions comprising PCSK9-binding molecules and methods of use | May 15, 2023 | Issued |
Array
(
[id] => 20213594
[patent_doc_number] => 12410236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Compositions comprising PCSK9-binding molecules and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/318343
[patent_app_country] => US
[patent_app_date] => 2023-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6027
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18318343
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/318343 | Compositions comprising PCSK9-binding molecules and methods of use | May 15, 2023 | Issued |